PC_095 CIN II+ Detection Rates – Does Colposcopic Biopsy Strategy Matters? A multi-Center Analysis

Gabi Haran 1 , Liron Kogan 1,2 , Gadi Ben Shitrit 1 , Zvi Vaknin 3,4 , Avinoam Tzabari 5 ,
Yoav Baruch 1,4,6 1. Assuta Medical Centers, Colposcopy & Cervical pathology Unit, Israel. 2. HaEmek Medical Center, Department of Gynecology, Israel.; 3. Yitzhak Shamir Medical Center, Gynecologic Oncology Unit, Israel.  4. Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel Aviv, Israel. 5. Maayanei Hayeshua Medical Center, Department of Gynecology, Israel. 6. Ichilov Medical Center, Department of Gynecology, Israel

PC_072 Long-term HPV Clearance of APL-1702 in Patients with HSIL: A Post-Hoc Analysis of the APRICITY Study

L. Sui (1), F. Chen (2), P. Hillemanns (3), H. Ruan (4), X. Chen (5), Z. Novak (6), Y. Zhang (7), J. Su (8), L. Zhu (2), J. Lang (2)
(1) Obstetrics & Gynecology Hospital Of Fudan University, Shanghai, Chine, (2) Peking Union Medical College Hospital, Beijing, Chine, (3) Medizinische Hochschule Hannover, Hannover, Allemagne, (4) Nanjing Maternity And Child Health Hospital, Nanjing, Chine, (5) Wenzhou People’s Hospital, Wenzhou, Chine, (6) Aranyklinika Gynecology, Budapest, Hongrie, (7) Qilu Hospital Of Shandong University, Jinan, Chine, (8) Freelancer, Shanghai, Chine

PC_086 Digital health intelligence and community mobilization to expand HPV vaccine coverage and cervical cancer screening

R. Annette (1), S. Tércia (2), F. Herla (3), P. Fabiana (1), B. Regina Flavia (1), C. Marcella (4), D.S. Maria Eduarda (5), R. Samila (5)
(1) Grupo Mulheres Do Brasil, Fortaleza, Brésil, (2) Universidade Federal De Minas Gerais, Belo Horizonte, Brésil, (3) Universidade Federal Do Piauí, Fortaleza, Brésil, (4) Harvard Medical School | Mass General Hospital, Estados Unidos Da América, Brésil, (5) Universidade Federal Do Ceará, Fortaleza, Brésil